Zimmer Biomet (ZBH) PT Raised to $118 at Stifel After Doc Check
Tweet Send to a Friend
Stifel analyst Rick Wise raised the price target on Zimmer Biomet (NYSE: ZBH) to $118.00 (from $115.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
